Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience—ROSE Korea Study

J Jae Ryong Song U Un Chul Park C Christopher Seungkyu Lee J Jae Jin Cho J Jin Young Kim S Seung Chul Baek A Areum Jeong A Ashish Sharma J Jae Hui Kim M Min Sagong S Se Joon Woo B Baruch D. Kuppermann A Anat Loewenstein F Francesco Bandello C Carl D. Regillo L Luke Nicholson C Clara Vazquez-Alfageme N Nilesh Kumar N Nikulaa Parachuri S Seemantini Ayachit A Alay Banker K Kourous A. Rezaei A Arshad M. Khanani P Peter K. Kaiser F Frank G. Holz (Department of Ophthalmology, University of Bonn, Bonn, Germany) S Sobha Sivaprasad T Taku Wakabayashi (Graduate School of Science) G Giuseppe Querques � Şengül Özdek K Kodjikian Laurent A Alper Bilgic P Paolo Lanzetta C Caroline R. Baumal N Nancy Holekemp T Taiji Sakamoto A Adnan Tufail N Nicolas Yannuzzi G Giulia Corradetti J Jay Sheth C Chitaranjan Mishra D Debdulal Chakraborty D David Boyer A Aleksandra Rachitskaya T Tunde Peto M Maximilian W. M. Wintergerst V Valentina Sarao B Barbara Parolini K Khalil Ghasemi Falavarjani Q Quan Dong Nguyen D Diana V. Do P Pearse A. Keane T Tarek Hassan (Boston University and National Bureau of Economic Research ,) J Jayanth Sridhar D David Eichenbaum D Dilraj S. Grewal F Francesc March M Martin Spitzer M Martin S. Zinkernagel T Tomoko Ueda-Consolvo M Masaaki Ishida T Tomoko Nakamura S Shuichiro Yanagisawa K Kotaro Tsuboi A Atsushi Hayashi J Judy Kim